Article
MicroRNA-Related Polymorphisms in PI3K/Akt/mTOR Pathway Genes Are Predictive of Limited-Disease Small Cell Lung Cancer Treatment Outcomes.
BioMed research international - 1 Jan 2017
Jiang Wei, Zhang Wenjue, Wu Lihong, Liu Lipin, Men Yu, Wang Jingbo, Liang Jun, Hui Zhouguang, Zhou Zongmei, Bi Nan, Wang Luhua
Abstract excerpt
The phosphoinositide-3 kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) signaling pathway plays an important role in cancer progression and treatment, including that of small cell lung cancer (SCLC), a disease with traditionally poor prognosis. Given the regulatory role of microRNA (miRNA) in gene expression, we examined the association of single nucleotide polymorphisms (SNPs) at miRNA-binding sites of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
